Cooper Companies Inc Forecasted to Post Q1 2018 Earnings of $2.55 Per Share (COO)
Cooper Companies Inc (NYSE:COO) – Investment analysts at Northcoast Research lifted their Q1 2018 earnings estimates for shares of Cooper Companies in a research report issued on Wednesday. Northcoast Research analyst D. Keiser now forecasts that the medical device company will post earnings per share of $2.55 for the quarter, up from their previous forecast of $2.48. Northcoast Research also issued estimates for Cooper Companies’ Q2 2018 earnings at $3.02 EPS.
Cooper Companies (NYSE:COO) last issued its earnings results on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.64 by $0.01. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The firm had revenue of $561.50 million during the quarter, compared to the consensus estimate of $558.86 million. During the same quarter in the prior year, the firm earned $2.28 earnings per share. The business’s quarterly revenue was up 8.3% on a year-over-year basis.
Shares of Cooper Companies (COO) traded up $0.33 during trading hours on Friday, reaching $235.52. 578,300 shares of the company’s stock traded hands, compared to its average volume of 547,517. Cooper Companies has a 1 year low of $179.41 and a 1 year high of $256.39. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.41 and a quick ratio of 1.26. The company has a market capitalization of $11,620.00, a P/E ratio of 31.32, a PEG ratio of 1.90 and a beta of 0.54.
The business also recently disclosed a semiannual dividend, which will be paid on Friday, February 9th. Stockholders of record on Tuesday, January 23rd will be given a $0.03 dividend. This represents a dividend yield of 0.03%. The ex-dividend date is Monday, January 22nd. Cooper Companies’s payout ratio is presently 0.80%.
In other Cooper Companies news, CEO Robert S. Weiss sold 32,500 shares of the stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $224.70, for a total transaction of $7,302,750.00. Following the sale, the chief executive officer now directly owns 119,111 shares in the company, valued at $26,764,241.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Allan E. Rubenstein sold 500 shares of the stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $222.00, for a total transaction of $111,000.00. Following the sale, the director now owns 6,590 shares in the company, valued at $1,462,980. The disclosure for this sale can be found here. Insiders sold 54,385 shares of company stock worth $12,289,463 over the last three months. Insiders own 1.60% of the company’s stock.
Institutional investors have recently made changes to their positions in the business. BlackRock Inc. grew its position in Cooper Companies by 4.5% in the 2nd quarter. BlackRock Inc. now owns 3,210,032 shares of the medical device company’s stock valued at $768,546,000 after purchasing an additional 138,395 shares during the period. Stevens Capital Management LP acquired a new position in Cooper Companies in the second quarter valued at about $1,043,000. Profund Advisors LLC boosted its position in Cooper Companies by 6.1% in the second quarter. Profund Advisors LLC now owns 2,184 shares of the medical device company’s stock valued at $523,000 after buying an additional 125 shares in the last quarter. Thrivent Financial For Lutherans raised its stake in shares of Cooper Companies by 0.3% in the second quarter. Thrivent Financial For Lutherans now owns 12,410 shares of the medical device company’s stock worth $2,971,000 after acquiring an additional 40 shares during the last quarter. Finally, Quantitative Investment Management LLC raised its stake in shares of Cooper Companies by 66.4% in the second quarter. Quantitative Investment Management LLC now owns 49,600 shares of the medical device company’s stock worth $11,875,000 after acquiring an additional 19,800 shares during the last quarter. Hedge funds and other institutional investors own 96.73% of the company’s stock.
WARNING: This news story was published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://www.watchlistnews.com/cooper-companies-inc-forecasted-to-post-q1-2018-earnings-of-2-55-per-share-coo/1813872.html.
Cooper Companies Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.